Fed. Circ. Sides With GSK, Others In Argatroban IP Row
The Federal Circuit upheld a win Tuesday for GlaxoSmithKline PLC, Mitsubishi Chemical Corp. and Encysive Pharmaceuticals Inc. in a patent battle with Barr Laboratories Inc. over anti-coagulant drug Argatroban, affirming a...To view the full article, register now.
Already a subscriber? Click here to view full article